Clinical trials
Recruiting Alzheimer Disease trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 4 |
| Washington University School of Medicine | 3 |
| Ludwig-Maximilians - University of Munich | 2 |
| Eidos Therapeutics, a BridgeBio company | 1 |
| Heinrich-Heine University, Duesseldorf | 1 |
| Karuna Therapeutics, Inc., a Bristol Myers Squibb company | 1 |
| Max-Planck-Institute of Psychiatry | 1 |
| NSC-Therapeutics | 1 |
| Novartis Pharmaceuticals | 1 |
| RWTH Aachen University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 20 |
| Dementia | 8 |
| Cognitive Dysfunction | 6 |
| Amyloid Neuropathies, Familial | 2 |
| Psychomotor Agitation | 2 |
| Amyloidosis | 1 |
| Cardiomyopathies | 1 |
| Dementia, Vascular | 1 |
| Heart Diseases | 1 |
| Major Depressive Disorder | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.